By proceeding, you agree to our Terms of Use and Privacy Policy.
Chief Scientific Officer
#gpcr #antibodies #ionchannels #drugdiscovery #proteinengineering
#Europe
Aneesh Vellatt Co-founder and Chief Scientific Officer at Maxion Therapeutics
Hematology / Oncology fellow
#immunoassays #proteinengineering
#NorthAmerica
4 years of experience as an analyst and researcher at IDF, integrating complex information into concise reports for policy makers while working under pressure and meeting tight deadlines; over 2 years
Senior Research Scientist II
#proteinpurification #proteinengineering #proteinexpression
Brandon Coyle holds a prominent role as a Senior Research Scientist II at Gilead Sciences, a renowned biopharmaceutical company at the forefront of medical innovation. With a remarkable background in
Senior Vice President & Chief Scientific Officer
Extensive industry experience in translational research, business development, field KOL interaction, leading strategic and research planning of drug development.
Application Scientist
#proteinengineering #formulation
David Golonka is a Scientist at the Application Laboratory of Wyatt Technology Europe GmbH, the leading provider of light scattering instruments for the solution-based characterization of macromolecul
Chief Technology Officer
#cellengineering #analyticalgenomics #proteinengineering
#Northamerica
Edward Rebar is a seasoned R&D executive with an impressive 15-year track record of leadership in the development of genome-targeting therapies and cutting-edge technologies. His expertise lies in str
Senior Scientist
#ProteinEngineering #CellBasedAssays #Biopharmaceuticals
Biochemist with strong background in development and characterization of experimental biotherapeutics, e. g., antibody fusion proteins and TNF superfamily ligands.
Professor
#Biochemistry #Biotechnology #ProteinEngineering
Research focus on Protein Engineering and Formulation for increasing stability, particularly against aggregation. This is aimed at improving biologics manufacturing, dosage form stabilisation, biocata
Global Head of AI Platforms, VP Insilico Medicine
#drugdesign #smallmoleculediscovery #proteinengineering #biologics
Petrina Kamya, PhD, is the Head of AI Platforms for Insilico Medicine, overseeing the business development of Insilico’s end-to-end AI-driven drug discovery platform, Pharma.AI, which includes novel t
Professor of Biologics Design
#proteinengineering #drugdiscovery
Shohei is currently working as a Professor of Biologics Design at NYU Langone Health
Associate Director, Protein Engineering Research
#molecularbiology #proteinengineering
Stephen Harper is currently working as Associate Director, Protein Engineering Research at Immunocore.
Co-founder & CEO
#machinelearning #proteinengineering
Surge Biswas is the Co-Founder & CEO at Nabla Bio. Surge was previously a Graduate Student at George Church Lab where they worked on machine learning guided protein design. Prior to that, they were a